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ABSTRACT  
Background: Allium ascalonicum Linn. (Liliaceae) is a mildly aromatic annual herb used to 
flavor food. Ethnobotanical survey revealed application of A. ascalonicum in the treatment of 
central nervous system (CNS) disorders.  
 
Objective:  To  investigate  the  anxiolytic  activity  of  aerial  part  hydroethanolic  extract  of  A. 
ascalonicum.    
 
Methods:  The  hole-board,  elevated  plus  maze,  light/dark  exploration,  open  field  and  social 
interaction tests were used in this study. Groups of mice were treated orally with distilled water 
(10 ml/kg), diazepam (1 mg/kg), and A. ascalonicum (50-400 mg/kg). Evaluations were done 1 h 
post-treatment and the duration of observation was mostly 5 min. In the hole-board test, mice 
were  observed  for  number/duration  of  head  dips  and  number  of  sectional  crossings.  In  the 
elevated plus maze test, the time spent in the open/closed arms and the number of entries by mice 
were observed. In the light/dark exploration test, the latency of entry into the dark box, time 
spent  in  the  light  and  dark  compartments,  number  of  rearing  and  assisted  rearing  were 
determined. In respect of the open field test, observations were made for the number of rearing, 
assisted  rearing,  and  sectional  crossings.  In  the  social  interaction  test,  pairs  of  mice  were 
observed for number of interactions including sniffing, following, and partner grooming.        
            
Results:  In  the  hole-board  test,  A.  ascalonicum  significantly  (p<0.05,  0.01)  increased  the 
number/duration of head dips and number of sectional crossings. In the elevated plus maze test, 
A. ascalonicum significantly (p<0.05) increased the number of entries into the open arm with Functional Foods in Health and Disease 2012, 2(11):448-459  Page 449 of 459 
corresponding reduction in number of entries into the closed arm. In the light/dark exploration 
test, A. ascalonicum significantly (p<0.05, 0.01) increased the latency of entry into the dark box, 
time spent in the light box, and number of rearing and assisted rearing. In respect of the open 
field  test,  A.  ascalonicum  significantly  (p<0.05,  0.01)  increased  the  number  of  sectional 
crossings  and  rearing.  Considering  the  social  interaction  test,  A.  ascalonicum  significantly 
(p<0.05) increased the number of interactions. Peak anti-anxiety effects were mostly observed at 
the dose of 100 mg/kg.              
 
Conclusion: The aerial part hydroethanolic extract of Allium ascalonicum possesses anxiolytic 
properties.  
 
Keywords:  Allium  ascalonicum,  Liliaceae,  anxiolytic  activity,  medicinal  plants,  traditional 
medicine.   
 
 
INTRODUCTION:  
Medicinal plants have continued to be relevant in the treatment of diverse disease conditions 
across the world in developing and developed countries.  Wambebe [1] and Gilani and Atta-ur-
Rahman [2] respectively reported that 70% of indigenous populations in developing countries 
rely on phytotherapy and 25% of drugs in typical western pharmacies are plant-derived. The 
official recognition of traditional medical practices, including the application of botanicals, and 
successful integration into the national healthcare delivery system in countries like China and 
Indian is indicative of the therapeutic values of herbal remedies. The reliability of history of use 
in ethnomedicine is significant to the extent that it is a prominent rationale for the selection of 
plants  for  scientific  scrutiny  towards  the  discovery  of  new  drugs  and  lead  compounds.  The 
motivation for the search for new drugs from plants is to discover medicines with enhanced 
efficacy and safety profile compared to presently available drugs.    
Health problems warranting the use of drugs which impact on the central nervous system, 
including anxiolytics, sedatives, antidepressants, antipsychotics et al., are a common and costly 
problem worldwide and traditional African healers treat mental illnesses and disorders of the 
CNS using a variety of indigenous plants [3, 4]. The perceived advantages ascribed to effective 
botanicals include relative safety, availability, and cheaper cost.   
 Allium  ascalonicum  Linn.(Liliaceae),  commonly  called  shallot  and  spring  onion,  is  an 
annual herbaceous plant widely found in Nigeria. The plant, widely used to flavor food, is locally 
known in the country as Alubosa-elewe, Albasa and Maigo. Ethnobotanical survey conducted 
among traditional medicine practitioners, who engage in herbalism, in Mushin area of Lagos 
State, Nigeria, revealed wide application of  A. ascalonicum in the treatment of CNS related 
disorders.  This  study  was  designed  to  investigate  the  anxiolytic  activity  of  aerial  part 
hydroethanolic extract of A. ascalonicum in mice.   
 
MATERIALS AND METHODS:                         
This  study,  conducted  to  investigate  the  anxiolytic  activity  of  the  aerial  part  hydroethanolic Functional Foods in Health and Disease 2012, 2(11):448-459  Page 450 of 459 
extract  of  A.  ascalonicum  in  Swiss  mice,  lasted  for  6  months  and  commenced  with  the 
procurement of the plant material and extraction in the month of April 2011. Acute toxicity test 
and phytochemical analysis were initially carried out followed by the evaluation of anxiolytic 
activity  using  hole-board,  elevated  plus  maze,  open-field,  light/dark  exploration  and  social 
interaction tests in acclimatized experimental animals.        
 
Plant material and extraction: A. ascalonicum aerial parts were obtained from a traditional 
herb dealer in Mushin, Lagos State, Nigeria. The plant was identified and authenticated by Prof. 
J.D. Olowokudejo  and Mr. T.K. Odewo of the Department  of Botany, University of  Lagos, 
Nigeria.  A  voucher  specimen,  numbered  LUH3559,  was  deposited  at  the  herbarium  of  the 
Department.   
Fresh aerial parts of A. ascalonicum were rinsed in water, cut into small pieces, and pounded 
into fine slurry with mortar and pestle. One hundred g of the material was macerated for 48 h in 
1 L hydroethanol (1:1) and exhaustive extraction was achieved by macerating the derived residue 
again in hydroethanol for 48 h (× 2). The filtrates obtained from each maceration process were 
combined and evaporated to dryness at 40
oC under reduced pressure. A dark brown solid extract 
with a yield of 40% was obtained. The dried extract was reconstituted in distilled water before 
each experimental session.  
 
Experimental animals: Swiss mice (15-30 g) of both sexes used in this study were obtained 
from  the  Laboratory  Animal  Center  of  College  of  Medicine,  University  of  Lagos,  Lagos, 
Nigeria.  The  animals  were  kept  in  well-ventilated  hygienic  compartments  maintained  under 
standard  environmental  conditions  (23-25ºC,  12  h/12  h  light/dark  cycle)  and  were  fed  with 
standard rodent diet (Livestock Feed PLC, Lagos, Nigeria) and water  ad libitum. Mice were 
acclimatized for 14 days before the commencement of the experiment. The protocol adopted in 
this study was in accordance with the provisions of the Experimentation Ethics Committee on 
Animal Use of the College of Medicine, University of Lagos, Lagos, Nigeria and the United 
States National Academy of Sciences Guide for the Care and Use of Laboratory Animals [5].          
 
Acute toxicity test:   
Animals used in this study were fasted for 12 h prior to the commencement of the experiment. 
The aerial part hydroethanolic extract of A. ascalonicum was administered orally (p.o.) up to 10 
g/kg  to  groups  of  mice.  The  extract  was  also  administered  to  4  groups  of  5  mice  each 
intraperitoneally (i.p.) at doses of 1000, 2000, 3000, and 5000 mg/kg. Separate groups of mice 
which served as control received distilled water at the highest volume of the extract administered 
for p.o. and i.p. routes. In all cases, animals were observed for 2 h post-treatment for behavioral 
changes  and  signs  of  toxicity.  Mortality  was  recorded  24  h  later  and  surviving  mice  were 
observed for a further 14 days for signs of delayed toxicity. The LD50 was estimated by the log 
dose-probit analysis method of Miller and Tainter [6].   
                                                
Phytochemical analysis: Phytochemical screening was carried out on A. ascalonicum extract 
using the methods of Trease and Evans [7] to determine the presence of various major classes of Functional Foods in Health and Disease 2012, 2(11):448-459  Page 451 of 459 
phytoconstituents.     
 
Anxiolytic activity tests:                       
Hole-board test: The hole-board is a white painted wooden board (40 cm × 40 cm) with four 
equidistant holes (1 cm diameter × 2 cm depth). Using two thick colored lines which intersect at 
the centre, the board was divided into 4 equal sectional squares of 20 cm × 20 cm [4]. One hour 
after oral treatment of 6 groups of 5 mice each with distilled water (10 ml/kg), A. ascalonicum 
(50, 100, 200 and 400 mg/kg) and diazepam (1 mg/kg), each mouse was placed in turn at one 
corner of the board with the animal subsequently moving about and dipping its head into the 
holes. The number and duration of head dips, and number of sectional crossings in 5 min. were 
recorded for individual mouse [8].       
 
Elevated plus maze test: The plus maze consists of two open arms and two closed arms (50 × 
10  ×  40  cm  each)  elevated  to  a  height  of  50  cm  [9].  Distilled  water  (10  ml/kg,  p.o),  A. 
ascalonicum (50, 100, 200 and 400 mg/kg, p.o) and diazepam (1 mg/kg, p.o) were administered 
to 6 groups of 5 mice each. One hour post-treatment, each mouse was placed in turn in the centre 
of the maze facing one of the closed arms. The cumulative times spent by each mouse in the 
open and closed arms of the maze and the number of entries was recorded for 5 min.     
 
Open-field test: Thirty mice allotted into 6 groups of 5 animals each were used in this study. 
The apparatus was made of wood 50 cm in length, 50 cm in width, and 25 cm in height. The 
plain floor of the box was divided into 8 cm by 8 cm, with 16 squares on it. Sixteen squares were 
defined as the center and the others adjacent to the walls as the periphery. A 60 W white bulb 
illuminated the apparatus. One hour after oral administration with vehicle (distilled water 10 
ml/kg), standard (diazepam 1 mg/kg), and extract (50, 100, 200, and 400 mg/kg), each mouse 
was gently placed at the center of the open field and number of squares crossed was counted for 
5 min. The mouse was taken out of the apparatus after 5 min. and the floor was cleaned with 
ethanol. A mouse was deemed to have crossed over from one square to another when all four 
paws had crossed. The number of rearings and assisted rearings (when the fore paws are placed 
on a wall of the open field) within the observation period of 5 min. was recorded [8, 10].    
 
Light/dark exploration test: Natural aversion of rodents from brightly lit places was evaluated 
in the light/dark transition model. The light/dark box is a rectangular box of 50 × 25 × 25 cm, 
which is divided into 2 compartments (light and dark). For this experiment, albino mice were 
divided  into  six  groups,  each  group  comprising  of  five  animals.  Vehicle  (distilled  water  10 
ml/kg),  standard  (diazepam  1  mg/kg),  and  extract  (50,  100,  200,  and  400  mg/kg)  were 
administered  p.o.  One  hour  after  administration,  each  mouse  was  placed  individually  in  the 
illuminated part of the light/dark box. During the test session of 5 min., latency (the time it takes 
for the animal to move into the dark compartment for the first time), number of entries into the 
light and dark compartments, total time spent in the light compartment, and visible number of 
rearings and assisted rearings were recorded [8, 11].    
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Social interaction test: In this test, the amount of time a pair of mice spend socially interacting 
with one another reflects the level of anxiety. The duration of social interaction decreases with 
increased anxiety. Mice were placed individually in the test arena for 7 min. familiarization 
session on two consecutive days. On the test day, groupings and treatments were done: distilled 
water (10 ml/kg; Group 1), diazepam (1 mg/kg; Group 2), and A. ascalonicum (50, 100, 200, and 
400 mg/kg; Groups 3, 4, 5, and 6). Two randomly selected mice from the same group were 
placed in adjacent cages in the waiting area of the test room. One hour post-treatment, each pair 
of mice were in turn introduced together into the center of the test arena. Social interaction was 
observed  remotely  for  7  min.  The  number  of  occurrences  of  social  interactions  (sniffing, 
following, and grooming the partner) were recorded [12].    
 
Statistical analysis: Results obtained in this study were expressed as mean ± S.E.M. (n = 5). The 
data were analyzed using One-way ANOVA (followed by Tukey’s post-hoc test) and Student’s 
t-test (unpaired, two-tailed) using GraphPad Prism 5 Software (GraphPad Software Inc., CA, 
USA). Results were considered significant when P < 0.05.         
 
RESULTS:   
Acute toxicity test: A. ascalonicum did not produce any mortality administered orally up to 10 
g/kg, but mice manifested signs of sedation like quiescence and reduced locomotion at the higher 
doses of 5-10 g/kg when observed for 2 h post-treatment. No visible signs of delayed toxicity 
and mortality were observed when the animals were monitored for a further 14 days. In respect 
of the i.p. route, mortality was 20 and 100 % respectively at the lowest dose of 1000 and highest 
dose of 5000 mg/kg. At the higher doses of 3000 and 5000 mg/kg, animals showed signs of 
sedation and writhing. The LD50 administered i.p. was estimated to be 2238.72 mg/kg. 
 
Phytochemical analysis: Preliminary screening of A. ascalonicum extract revealed the presence 
of alkaloids, tannins, glycosides, anthraquinones, phlobatannins, and flavonoids.    
 
Anxiolytic activity tests:   
Hole-board test: A. ascalonicum significantly (p<0.05, 0.01) and dose-dependently increased 
the number of head dips with values being 2.00 ± 0.32, 3.80 ± 0.80, 4.40 ± 0.87 and 5.80 ± 0.86 
respectively at doses of 50, 100, 200, and 400 mg/kg, compared to a value of 1.20 ± 0.37 for 
control. Peak effect was produced at the dose of 400 mg/kg. Diazepam slightly increased the 
number of head dips but this effect was not significant. The value for the extract at 400 mg/kg 
was significantly (p<0.01) higher than that of diazepam (5.80 ± 0.86 vs. 1.60 ± 0.24).  In respect 
of duration of head dips, A. ascalonicum significantly (p<0.01,0.001) increased the duration of 
head dips  giving values of 32.50 ± 4.37, 36.50 ± 7.19, 30.00 ± 7.02,  and 16.00 ± 5.82 seconds 
relative to 3.00 ± 1.23 seconds for control. Peak effect was produced at the dose of 100 mg/kg. 
Diazepam increased the duration of head dips but this effect was also not significant. The effect 
of the extract at the dose of 100 mg/kg was higher than that of diazepam. For the number of 
sectional crossings, there was no significant difference between the effect of diazepam (5.20 ± 
1.59) and control (3.80 ± 1.46). A. ascalonicum significantly (p<0.001) increased the number of Functional Foods in Health and Disease 2012, 2(11):448-459  Page 453 of 459 
sectional crossings at doses of 100, 200, and 400 mg/kg with peak effect produced at dose of 200 
mg/kg. This effect was significantly (p<0.01) higher than that of diazepam (Table 1).   
 
Table 1: Effect of A. ascalonicum aerial part hydroethanolic extract in Hole board test 
 
Treatment  Dose 
 
 (mg/kg) 
No of head dips 
 
Duration of 
head dips 
(seconds) 
No. of sectional 
crossings 
Distilled water  (10 ml/kg)  1.20 ± 0.37  3.00 ± 1.23  3.80 ± 1.46 
Diazepam  1  1.60 ± 0.24  14.75 ± 6.25  5.20 ± 1.59 
A. ascalonicum  50  2.00 ± 0.32  32.50 ± 4.37
c  5.20 ± 1.63 
A. ascalonicum  100  3.80 ± 0.80
a  36.50 ± 7.19
b  15.40 ± 1.25
c 
A. ascalonicum  200  4.40 ± 0.87
b  30.00 ± 7.02
b  19.00 ± 2.32
c,β 
A. ascalonicum  400  5.80 ± 0.86
b,β  16.00 ± 5.82  16.60 ± 1.44
c 
 
Values are mean ± S.E.M (n = 5). 
ap< 0.05, 
bp< 0.01, 
cp<0.001 vs. Distilled water; 
βp<0.01 vs. Diazepam.      
 
Elevated plus maze test:  As shown in  Table 2, A. ascalonicum produced a non-significant 
increase in the time spent in the open arms with peak effect produced at the dose of 100 mg/kg 
(276.5 ± 4.74 seconds) relative to control (180.0 ± 51.30 seconds). In respect of entry into open 
arms, the extract at the dose of 100 mg/kg significantly (p<0.05) increased the number of entries 
(8.20 ±0.73) compared to control (4.60 ± 1.33). The number of entries into the closed arms was 
significantly (p<0.05) reduced by A. ascalonicum at doses of 50 and 400 mg/kg, and diazepam, 
with values of 4.20 ± 1.50, 3.20 ± 1.74, and 3.40 ± 1.50
 respectively, compared to control (8.20 ± 
0.86). The effect produced by the extract at the dose of 400 mg/kg was comparable to that of 
diazepam.        
 
Table 2: Effect of A. ascalonicum aerial part hydroethanolic extract in Elevated plus maze test  
 
Treatment  Dose 
(mg/kg) 
 
Time spent in 
open arms 
(seconds) 
No. of entries 
into open arms 
No. of entries 
into closed 
arms 
Distilled water  (10 ml/kg)  180.00 ± 51.30  4.60 ± 1.33  8.20 ± 0.86 
Diazepam  1  206.50 ± 30.29  6.20 ± 1.66  3.40 ± 1.50
a 
A. ascalonicum  50  255.30 ± 8.12  5.80 ± 0.92  4.20 ± 1.50
a 
A. ascalonicum  100  276.50 ± 4.74  8.20 ± 0.73
a  7.00 ± 0.71 
A. ascalonicum  200  231.50 ± 10.05  7.40 ± 0.93  8.40 ± 1.57 
A. ascalonicum  400  198.50 ± 45.68  4.80 ± 1.11  3.20 ± 1.74
a 
 
Values are mean ± S.E.M. (n = 5). 
ap<0.05 vs. Distilled water.  
 
Open-field test: As shown in Table 3, diazepam (p<0.05) produced a slight non-significant 
increase in the number of rearing compared to control (9.60 ± 1.75 vs. 7.60 ± 2.25). At the dose 
of 100 mg/kg, A. ascalonicum produced a significant (p<0.05) increase in the number of rearing Functional Foods in Health and Disease 2012, 2(11):448-459  Page 454 of 459 
giving a value of 15.60 ± 1.69 relative to control. This effect was significantly (p<0.05) higher 
than that of diazepam. In respect of assisted rearing, diazepam also non-significantly increased 
the  number  of  assisted  rearing  compared  to  control  (17.20  ±  2.75  vs.  11.60  ±  3.76).  A. 
ascalonicum at the dose of 100 mg/kg increased the number of assisted rearing (20.00 ± 1.09) 
but  this  effect  was  not  significant.  For  the  number  of  sectional  crossings,  A.  ascalonicum 
significantly  (p<0.05,  0.01)  increased  the  number  of  sectional  crossings  with  peak  effect 
produced at the dose 100 mg/kg with a value of 71.40 ± 3.23 compared to 49.40 ± 4.23 for 
control. Diazepam also significantly (p<0.01) increased the number of sectional crossings (69.80 
± 3.43) relative to control. The effects of A. ascalonicum at 100 mg/kg and diazepam were 
comparable and not significantly different (p>0.05). There was no significant difference between 
the effects of the extract at the various doses.    
 
Table 3: Effect of A. ascalonicum aerial part hydroethanolic extract in the Open field test  
 
Treatment  Dose (mg/kg) 
 
No. of rearing  No. of assisted 
rearing 
No. of sectional 
crossings 
Distilled water  (10 ml/kg)  7.60 ± 2.25  11.60 ± 3.76  49.40 ± 4.23 
Diazepam  1  9.60 ± 1.75  17.20 ± 2.75  69.80 ± 3.43
b 
A. ascalonicum  50  7.20 ± 3.79  14.00 ± 1.70  68.40 ± 5.64
a 
A. ascalonicum  100  15.60 ± 1.69
a,α  20.00 ± 1.09  71.40 ± 3.23
b 
A. ascalonicum  200  4.20 ± 1.93  12.20 ± 0.97  52.80 ± 3.89 
A. ascalonicum  400  9.60 ± 1.97  16.60 ± 2.18  68.20 ± 5.17
a 
 
Values are mean ± S.E.M. (n = 5). 
ap<0.05, 
bp< 0.01 vs. Distilled water; 
αp<0.05 vs. Diazepam.      
 
Light/dark exploration test:   
As shown in Table 4, A. ascalonicum at doses of 50-200 mg/kg significantly (p<0.05, 0.01) 
increased the latency of entry into the dark box with peak effect produced at the dose of 100 
mg/kg (5.60 ± 0.51 seconds) compared to control (1.80 ± 0.66 seconds). The extract at doses of 
100-400 mg/kg significantly (p<0.05, 0.01) increased the time spent in the light box with peak 
effect at the dose of 100 mg/kg (136.0 ± 21.45 seconds) compared to control (34.00 ± 5.63 
seconds). The effect at this dose was not significantly different from that of diazepam (84.00 ± 
16.29 seconds). In respect of rearing, A. ascalonicum at doses of 100-400 mg/kg significantly 
(p<0.05, 0.01) increased the number of rearing with peak effect at the dose of 100 mg/kg (4.80 ± 
1.32) relative to control (0.40 ± 0.40). Considering assisted rearing, the extract at doses of 50-
400 mg/kg also significantly (p<0.05, 0.01) increased the number of assisted rearing but peak 
effect was at the dose of 400 mg/kg (11.00 ± 1.92) compared to control (1.60 ± 0.93). In respect 
of latency of entry into the dark box and number of rearing, the values for A. ascalonicum at the 
dose of 100 mg/kg were significantly (p<0.05, 0.001) higher than the values for diazepam.           
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Table 4: Effect of A. ascalonicum aerial part hydroethanolic extract in the Light/dark exploration 
test   
 
Treatment  Dose 
(mg/k
g) 
Latency of 
entry into 
the dark 
box(seconds)  
Time in 
light box 
(seconds) 
Time in dark 
box (seconds) 
No. of 
rearing 
No. of 
assisted 
rearing 
Distilled water  (10 
ml/kg) 
1.80 ± 0.66  34.00 ± 5.63  218.00 ± 23.59  0.40 ± 0.40  1.60 ± 0.93 
Diazepam  1  1.80 ± 0.20  84.00 ± 16.29
a  119.00 ± 9.12
b  0.80 ± 0.37  7.60 ± 1.21
b 
 
A. ascalonicum  50  4.80 ± 0.66
a  56.40 ± 9.24  192.00 ± 18.94  0.80 ± 0.58  6.80 ± 0.80
b 
 
A. ascalonicum  100  5.60 ± 0.51
b,γ  136.00±21.45
b  163.20 ± 27.60  4.80±1.32
a,α   10.60 ±1.78
b 
 
A. ascalonicum  200  3.80 ± 0.37
a  68.40 ± 13.55
a  117.40 ± 20.44  4.40 ± 0.98
b  9.60 ± 2.46
a 
 
A. ascalonicum  400  2.80 ± 0.20  108.00 ± 15.23
b  159.00 ± 10.55
α  3.20 ± 0.49
b  11.00 ±1.92
b 
 
 
Values are mean ± S.E.M. (n = 5).  
ap<0.05, 
bp<0.01 vs. Distilled water; 
αp< 0.05, 
γp<0.001 vs. Diazepam.       
 
Social interaction test: The number of social interactions in the control group was 13.67 ± 2.91. 
A. ascalonicum increased the number of social interactions with peak significant effect (p<0.01) 
observed at the dose of 100 mg/kg (28.33 ± 4.41). The value for diazepam (11.80 ± 0.80) was 
not significant (p>0.05) relative to the control (Table 5).  
 
Table 5:  Effect of A. ascalonicum aerial part hydroethanolic extract in the Social interaction test 
 
Treatment  Dose 
(mg/kg) 
Number of 
social interactions  
Distilled water   (10 ml/kg)  13.67 ± 2.91 
Diazepam  1  11.80 ± 0.80 
A. ascalonicum  50  19.33 ± 1.86 
A. ascalonicum  100  28.33 ± 4.41
b 
A. ascalonicum  200  27.67 ± 7.22 
A. ascalonicum  400  26.67 ± 4.41 
 
  Values are mean ± S.E.M (n = 5 pair). 
ap<0.05, 
bp<0.01 vs. Distilled water.        
 
DISCUSSION:   
Over  the  years,  different  pharmacological  models  have  been  employed  in  the  evaluation  of 
medicinal plants for neuropharmacological activities towards the identification of botanicals and 
drugs  with  beneficial  effects  in  the  treatment  of  diverse  CNS  disorders.  The  choice  of  test 
methods not only determines effectiveness but in some instances also gives an indication of the 
mechanism(s) of the test substance. In this study, the hole-board, elevated plus maze, light/dark Functional Foods in Health and Disease 2012, 2(11):448-459  Page 456 of 459 
exploration, open field and social interaction tests were used to investigate the anxiolytic effect 
of  the  aerial  part  hydroethanolic  extract  of  A.  ascalonicum  in  mice.  The  plant  is  a  mildly 
aromatic herb used like onions to flavor food, including meats and sauces [13]. Adeniyi and 
Anyiam [14] reported that the bulb of shallot is of considerable importance in African cooking 
and in salads.    
The hole-board model indicates that head-dipping behaviour is sensitive to changes in the 
emotional state of the animal and suggests that the expression of an anxiolytic state in animals 
may be reflected by an increase in head-dipping behaviour [8, 15]. In this study, A. ascalonicum 
significantly increased the number and duration of head dips with peak effects produced at doses 
of 400 and 100 mg/kg respectively, suggesting anxiolytic effect. At these doses, the extract also 
significantly increased the number of sectional crossings indicating that the anxiolytic effect of 
A. ascalonicum is associated with increase in locomotion.    
The elevated plus maze is a standard pharmacological model for evaluating the anxiolytic 
effect of drugs and it is based on the fact that exposure of animals to an elevated plus maze 
evoke approach-avoidance conflict stronger than elicited by the exposure to an enclosed arm [8, 
16].  Anxiolytic effect is indicated by decrease in aversion to the open arms by way of increase 
in time spent and entries into the open arms [8], while anxiogenic compounds reduce the value of 
these parameters [17]. In this study, A. ascalonicum at the dose of 100 mg/kg non-significantly 
increased the time spent in the open arms and significantly increased the number of entries into 
this  compartment.  As  observed  with  diazepam,  the  extract  at  doses  of  50  and  400  mg/kg 
significantly reduced the number of entries into the closed arms. The actions of A. ascalonicum 
in the elevated plus maze model in this study suggest anxiolytic property.    
Barua et  al.  [8] reported the anxiolytic effect  of a medicinal plant extract  based on the 
increase in the number of rearing and assisted rearing, and number of squares traversed in the 
open field test. In this study, A. ascalonicum extract at the dose of 100 mg/kg increased the 
number of rearing and assisted rearing with effect being significant in respect of the former 
parameter.  As  observed  with  diazepam,  the  extract  at  doses  of  50,  100,  and  400  mg/kg 
significantly increased the number of sectional crossings with peak effect produced at the dose of 
100 mg/kg. This observation is consistent with the results obtained in the hole-board test. The 
results obtained in the open field test also suggest that A. ascalonicum possess anxiolytic activity 
with associated enhancement of locomotion.   
According to Bourin and Hascoet [11], the light/dark test is based on the innate aversion of 
rodents to brightly illuminated areas and on the spontaneous exploratory behavior of rodents in 
response to mild stressors including novel environment and light. Accordingly, this test may be 
useful  to  predict  anxiolytic-like  or  anxiogenic-like  activity  in  mice.  Transitions  have  been 
reported to be an index of activity-exploration because of habituation over time, and the time 
spent in each compartment to be a reflection of aversion [18]. In this study, A. ascalonicum (50-
400 mg/kg) significantly increased the latency of entry into the dark compartment and time spent 
in  the  light  box.  Diazepam  also  significantly  increased  the  time  spent  in  the  light  box  and 
reduced the duration of stay in the dark section. The extract (50-400 mg/kg) also significantly 
increased the number of rearing and assisted rearing. Diazepam also increased the number of 
rearing and assisted rearing but the effect was only significant in respect of the later.  The effects Functional Foods in Health and Disease 2012, 2(11):448-459  Page 457 of 459 
observed with A. ascalonicum in the light/dark exploration test suggest anxiolytic activity with 
peak action generally elicited at the dose of 100 mg/kg.     
In the social interaction test, the amount of time a pair of rodents spend socially interacting 
with one another is thought to reflect the level of anxiety and the duration of social interaction 
decreases with increased anxiety [12]. Anxiolytic activity, apart from being indicated by increase 
in the duration of social interaction (by way of sniffing, following, and grooming), may also be 
suggested  by  increase  in  the  number  of  social  interaction  within  a  specified  period  of  time 
relative to the negative control group. In this study, A. ascalonicum increased the number of 
social interactions with significant and peak effect produced at the dose of 100 mg/kg. This result 
confirms the anxiolytic effect of the extract as indicated in the results obtained in the other 
established models used in this study.    
The pharmacological actions of medicinal plants are due to the presence and manifestations 
of bioactive compound(s). It has been established that a lot of plant secondary metabolites are 
being employed in the treatment of psychotic disorders especially anxiety in traditional medicine 
practice, most of which directly or indirectly affect the CNS, noradrenaline, serotonin, GABA 
and benzodiazepine neurotransmitters activities [8, 19, 20]. Phytochemical screening of the aerial 
part hydroethanolic extract of A. ascalonicum in this study revealed the presence of alkaloids, 
tannins,  glycosides,  anthraquinones,  phlobatannins,  and  flavonoids.  Previous  phytochemical 
analysis  of  shallot  extracts  has  confirmed  the  presence  of  flavone,  quercetins,  ascalin  and 
furostanol saponins [13, 21, 22]. The anxiolytic activity of A. ascalonicum identified in this study 
may be due to the presence of one or a combination of phytoconstituents present in the extract. 
Flavonoids, alkaloids, and terpenoids have been reported to be responsible for anxiolytic and 
sedative effects observed in different plant extracts [23-25]. According to Wasowski and Marder 
[26],  some  natural  flavonoids  have  been  shown  to  possess  selective  affinity  for  the 
benzodiazepine  binding  site  with  a  broad  spectrum  of  CNS  effects  and  a  list  of  successful 
synthetic derivatives has been generated with enhanced activities.  
In respect of acute toxicity, the aerial part hydroethanolic extract of A. ascalonicum did not 
produce any mortality and visible signs of delayed toxicity administered p.o. up to 10 g/kg.  
Hayes [27] stated that no dose-related toxicity should be considered above 5 g/kg body weight, 
thus suggesting that the extract is relatively non-toxic administered p.o. However, the LD50 when 
administered i.p. was estimated to be 2238.72 mg/kg.    
 
CONCLUSION: 
The results obtained in this study suggest that the aerial part hydroethanolic extract of Allium 
ascalonicum  possesses  anxiolytic  activity  due  to  one  or  a  combination  of  phytoconstituents 
identified in the extract. Further investigations are ongoing in our laboratory to isolate, identify 
and characterize the chemical principle(s) responsible for the observed biological property of the 
extract and the precise mechanism(s) of action.    
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